Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3,410.00 GBX | -1.16% | -4.35% | -32.48% |
11-19 | SkinBioTherapeutics Finalizes SkinBiotix Commercialization Deal with Croda | MT |
11-19 | Croda International plc Announces Directorate Change | CI |
Evolution of the Average Target: Croda International Plc
Evolution of the Target Price: Croda International Plc
Changes in Analyst Recommendations: Croda International Plc
Analyst Opinion | 4m Revision of opinion | Divergence of analysts' opinions | Divergence of Target Price | Ecart obj. / dr | ||
---|---|---|---|---|---|---|
+31.48% | ||||||
+10.39% | ||||||
+26.55% | ||||||
+7.61% | ||||||
+26.06% | ||||||
+13.78% | ||||||
+14.67% | ||||||
+8.09% | ||||||
+16.09% | ||||||
+43.73% | ||||||
Average | +19.84% | |||||
Weighted average by Cap. | +16.86% |
Analysts' Consensus
Analyst Consensus Detail
Consensus revision (last 18 months)
Analysts covering the company
JPMorgan | |
Redburn | |
Barclays | |
Goldman Sachs | |
UBS | |
Deutsche Bank Securities | |
Berenberg Bank | |
Jefferies & Co. | |
Bernstein | |
Stifel Nicolaus | |
Morgan Stanley | |
Bank of America Securities/Merrill Lynch | |
Citigroup | |
Credit Suisse |
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- CRDA Stock
- Consensus Croda International Plc
MarketScreener is also available in this country: United States.
Switch edition